Substance / Medication

Ceftobiprole

Overview

Active Ingredient
ceftobiprole
RxNorm CUI
2691333

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

Research Evidence

Published studies and systematic reviews

Sort:
Impact of obesity on clinical outcomes in patients treated with ceftobiprole: results from Phase 3 clinical trials.
Holland Thomas L, Shorr Andrew F, Overcash J Scott et al. · J Antimicrob Chemother · 2025
PMID: 40155066TrialFull text (PMC)
Ceftobiprole for Treatment of ComplicatedBacteremia.
Holland Thomas L, Cosgrove Sara E, Doernberg Sarah B et al. · N Engl J Med · 2023
PMID: 37754204Trial
Pharmacokinetics and Safety of Ceftobiprole in Pediatric Patients.
Rubino Christopher M, Polak Mark, Schröpf Sebastian et al. · Pediatr Infect Dis J · 2021
PMID: 34533489TrialFull text (PMC)
Aanalysis of two Phase III trials showing the efficacy and tolerability of ceftobiprole in East Asian patients.
Huang Haihui, Gao Lei, Engelhardt Marc et al. · Future Microbiol · 2021
PMID: 34155899Trial
Early improvement in severely ill patients with pneumonia treated with ceftobiprole: a retrospective analysis of two major trials.
Scheeren Thomas W L, Welte Tobias, Saulay Mikael et al. · BMC Infect Dis · 2019
PMID: 30808293TrialFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Health Goals

Goals connected through associated conditions

Quick Facts

Type
Substance / Medication
Fully Specified Name
Ceftobiprole (substance)
SNOMED CT
734512008
UMLS CUI
C1100584
RxNorm CUI
2691333

Clinical Data

This intervention maps to 8 entities in the Ltrl knowledge graph.

3
Conditions
2
Biomarkers
2
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Ltrl clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.